Editorial & Columns Patent Cliff: Opportunity for Indian Pharmaceutical Companies February 27, 2025 | Dr. Anil Kumar Angrish | No Comments | More
Editorial & Columns Pricing of Patented Drugs in India: Balancing the Interests of Patent Holders and Patients December 21, 2024 | Dr. Anil Kumar Angrish | No Comments | More
